VYGR - Voyager Therapeutics GAAP EPS of -$0.51 beats by $0.06 revenue of $4.85M beats by $3.25M
2023-08-03 07:09:18 ET
- Voyager Therapeutics press release ( NASDAQ: VYGR ): Q2 GAAP EPS of -$0.51 beats by $0.06 .
- Revenue of $4.85M (+583.1% Y/Y) beats by $3.25M .
For further details see:
Voyager Therapeutics GAAP EPS of -$0.51 beats by $0.06, revenue of $4.85M beats by $3.25M